Olivier Danos

Insider Reports History

Location
Rockville, MD
Signature
/s/ Patrick J. Christmas as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Olivier Danos:

Company Role Class Num Shares Value Price $ Report Date Ownership
REGENXBIO Inc. Chief Scientific Officer Common Stock 226,348 $1,826,628 $8.07 01 Feb 2025 Direct
REGENXBIO Inc. Chief Scientific Officer Stock Options (Right to buy) 95,721 02 Jan 2025 Direct

Insider Reports Filed by Olivier Danos

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RGNX REGENXBIO Inc. 01 Feb 2025 1 -$43,998 4 Chief Scientific Officer 04 Apr 2025, 17:16
RGNX REGENXBIO Inc. 02 Jan 2025 3 -$97,630 4 Chief Scientific Officer 06 Jan 2025, 16:59
RGNX REGENXBIO Inc. 01 Aug 2024 2 +$13,555 4 Chief Scientific Officer 05 Aug 2024, 18:38
RGNX REGENXBIO Inc. 02 Jan 2024 5 -$116,594 4 Chief Scientific Officer 04 Jan 2024, 16:22
RGNX REGENXBIO Inc. 03 Jan 2023 3 -$46,675 4 Chief Scientific Officer 05 Jan 2023, 15:06
RGNX REGENXBIO Inc. 01 Jan 2022 5 -$21,571 4 Chief Scientific Officer 04 Jan 2022, 20:04